|
Volumn 130, Issue 10, 2000, Pages 983-985
|
Cerivastatin modulates antiatherogenic properties of high-density lipoproteins in patients with coronary heart disease and hyperlipidemia
a a a a a a a |
Author keywords
Cerivastatin; Cholesterol binding capacity; High density lipoproteins; Phospholipids
|
Indexed keywords
APOLIPOPROTEIN A1;
CARDIOLIPIN;
CERIVASTATIN;
CHOLESTEROL;
HIGH DENSITY LIPOPROTEIN CHOLESTEROL;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
LYSOPHOSPHATIDYLCHOLINE;
PHOSPHATIDYLCHOLINE;
PHOSPHOLIPID;
PLACEBO;
SPHINGOMYELIN;
TRIACYLGLYCEROL;
ADULT;
AGED;
ANALYTICAL PARAMETERS;
ARTICLE;
ATHEROGENESIS;
CHOLESTEROL BLOOD LEVEL;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG EFFECT;
HUMAN;
HYPERLIPIDEMIA;
HYPOLIPEMIA;
INHIBITION KINETICS;
ISCHEMIC HEART DISEASE;
MALE;
RANDOMIZED CONTROLLED TRIAL;
TREATMENT OUTCOME;
ADULT;
AGED;
ARTERIOSCLEROSIS;
CHOLESTEROL;
CORONARY DISEASE;
DOUBLE-BLIND METHOD;
HUMANS;
HYPERLIPIDEMIAS;
LIPOPROTEINS, HDL;
MALE;
MIDDLE AGED;
PHOSPHOLIPIDS;
PYRIDINES;
|
EID: 0035060118
PISSN: 00074888
EISSN: None
Source Type: Journal
DOI: 10.1023/A:1002822109154 Document Type: Article |
Times cited : (2)
|
References (15)
|